Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.4600 (5.31%) ($14.7600 - $16.0000) on Mon. Jul. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.05% (three month average) | RSI | 87 | Latest Price | $15.4600(5.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 17.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) IWO(44%) ARKK(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.525% in a week (0% probabilities). VIXM(-32%) VXX(-27%) XLC(-9%) UUP(-9%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.525% (StdDev 7.05%) | Hourly BBV | 0 () | Intraday Trend | 2.8% | | | |
|
5 Day Moving Average | $14.72(5.03%) | 10 Day Moving Average | $13.88(11.38%) | 20 Day Moving Average | $12.12(27.56%) | To recent high | 0% | To recent low | 100.8% | Market Cap | $1.149b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |